Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma.
Journal
Targeted oncology
ISSN: 1776-260X
Titre abrégé: Target Oncol
Pays: France
ID NLM: 101270595
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
pubmed:
29
10
2020
medline:
29
10
2020
entrez:
28
10
2020
Statut:
ppublish
Résumé
An Online First version of this article was made available online at https://link.springer.com/article/10.1007/s11523-020-00757-3 on 12 October 2020. Errors were subsequently identified in the article, and the following corrections should be noted.
Identifiants
pubmed: 33113041
doi: 10.1007/s11523-020-00765-3
pii: 10.1007/s11523-020-00765-3
doi:
Types de publication
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Pagination
809-810Commentaires et corrections
Type : ErratumFor